AAMU
INO icon

Amundi Asset Management US’s Inovio Pharmaceuticals INO Stock Holding History

Amundi Asset Management US’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,420
Closed -$576K – 1560
2020
Q4 		$576K Buy
5,420
+4,145
+325% +$552K ﹤0.01% 1273
2020
Q3 		$177K Sell
1,275
-50
-4% -$10.4K ﹤0.01% 1397
2020
Q2 		$429K Buy
+1,325
New +$213K ﹤0.01% 1270
2018
Q4 		– Sell
-1,883
Closed -$126K – 1632
2018
Q3 		$126K Buy
1,883
+966
+105% +$53.8K ﹤0.01% 1505
2018
Q2 		$43K Hold
917
– – ﹤0.01% 1520
2018
Q1 		$52K Buy
917
+109
+13% +$5.9K ﹤0.01% 1485
2017
Q4 		$40K Buy
+808
New +$50.1K ﹤0.01% 1521

Other funds holding INO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return